Physicochemical properties of alginate-based films: Effect of ionic crosslinking and mannuronic and guluronic acid (cas 15769-56-9) ratio
-
Add time:09/09/2019 Source:sciencedirect.com
The use of alginates as films in food applications has increased in the recent years due to their swelling capacity and overall functionality. This behaviour is a result of their capacity to crosslink with Ca2+ ion. Aiming to fully understand the effect of calcium chloride (CaCl2) crosslinking and the mannuronic (M) and guluronic (G) acid ratio (M/G) of alginate structure in the films' properties, alginate-based films with different (M/G) ratios were crosslinked at increasing CaCl2 concentrations. Films were produced by casting, and characterized in terms of mechanical properties (tensile strength and elongation-at-break), opacity, water sensitivity (moisture content, solubility and water vapour permeability) and morphology, evaluated by scanning electronic microscopy (SEM). Chemical interactions were studied by Fourier Transform Infrared Spectroscopy (FTIR) to assess possible chemical modifications of alginate-based films after crosslinking. Crosslinking significantly affected the alginate structure and properties, decreasing film thickness, moisture content, solubility and water vapour permeability of the alginate-based films. The mechanical properties were also influenced by the crosslinking and high CaCl2 concentrations lead to an increase of tensile strength. Results showed a relation between M/G ratios and CaCl2 concentrations and the resulting film's properties. Alginate and the respective crosslinker should be chosen taking into account M/G ratio, since high contents of M residues lead to fragile and flexible films and high content of G residues to stronger films, and these properties are highly dependent on the concentration of CaCl2. Overall, alginate-based films are a good candidate to obtain tailored made edible films for food applications. Further investigation should be done to fully understand the effect of the alginate chain composition and order (e.g. MM, GG, GM, MG) in alginate-based films properties.
We also recommend Trading Suppliers and Manufacturers of guluronic acid (cas 15769-56-9). Pls Click Website Link as below: cas 15769-56-9 suppliers
Prev:Impact of hydrolysis conditions on the detection of mannuronic to guluronic acid (cas 15769-56-9) ratio in alginate and its derivatives
Next:Effect of alginate size, mannuronic/guluronic acid (cas 15769-56-9) content and pH on particle size, thermodynamics and composition of complexes with β-lactoglobulin) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- RESEARCH ARTICLE – Pharmaceutics, Drug Delivery and Pharmaceutical TechnologyNanoparticulate Assembly of Mannuronic Acid-and guluronic acid (cas 15769-56-9)-Rich Alginate: Oral Insulin Carrier and Glucose Binder09/27/2019
- Preparation and characterization of guluronic acid (cas 15769-56-9) oligosaccharides degraded by a rapid microwave irradiation method09/26/2019
- An in vitro evaluation of anti-aging effect of guluronic acid (cas 15769-56-9) (G2013) based on enzymatic oxidative stress gene expression using healthy individuals PBMCs09/25/2019
- Anti‐inflammatory and anti‐tumor effects of α-l-guluronic acid (cas 15769-56-9) (G2013) on cancer-related inflammation in a murine breast cancer model09/24/2019
- Effect of alginate size, mannuronic/guluronic acid (cas 15769-56-9) content and pH on particle size, thermodynamics and composition of complexes with β-lactoglobulin09/10/2019
- Impact of hydrolysis conditions on the detection of mannuronic to guluronic acid (cas 15769-56-9) ratio in alginate and its derivatives09/08/2019
- Effects of guluronic acid (cas 15769-56-9) (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathway09/07/2019
- The alginate lyase from Isoptericola halotolerans CGMCC 5336 as a new tool for the production of alginate oligosaccharides with guluronic acid (cas 15769-56-9) as reducing end09/06/2019
- Original articleThe safety and efficacy of guluronic acid (cas 15769-56-9) (G2013) in ankylosing spondylitis: A randomized controlled parallel clinical trial09/05/2019
-
Health and Chemical more >


